form
crystals
feed ratio
lactide:glycolide 50:50
mol wt
PEG average Mn 5,000, PLGA Mn 5,000
impurities
≤5000 ppm (GC)
storage temp.
−20°C
General description
通过 GC 分析含有 ≤500 ppm 杂质，包括痕量单体和残留有机物。
Application
生物相容性嵌段共聚物，可用于形成用于药物传递的纳米颗粒具有用于癌症药物、抗炎药、抗生素或麻醉剂的靶向或受控释放的潜力。
Still not finding the right product?
Explore all of our products under 聚(乙二醇)甲醚-嵌段-聚(丙交酯-co-乙交酯)
存储类别
11 - Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
Fabienne Danhier et al.
Journal of controlled release : official journal of the Controlled Release Society, 133(1), 11-17 (2008-10-28)
The purpose of this study was to develop Cremophor EL-free nanoparticles loaded with Paclitaxel (PTX), intended to be intravenously administered, able to improve the therapeutic index of the drug and devoid of the adverse effects of Cremophor EL. PTX-loaded PEGylated
Miles A Miller et al.
Nature communications, 6, 8692-8692 (2015-10-28)
Therapeutic nanoparticles (TNPs) aim to deliver drugs more safely and effectively to cancers, yet clinical results have been unpredictable owing to limited in vivo understanding. Here we use single-cell imaging of intratumoral TNP pharmacokinetics and pharmacodynamics to better comprehend their
R Gref et al.
Science (New York, N.Y.), 263(5153), 1600-1603 (1994-03-18)
Injectable nanoparticulate carriers have important potential applications such as site-specific drug delivery or medical imaging. Conventional carriers, however, cannot generally be used because they are eliminated by the reticulo-endothelial system within seconds or minutes after intravenous injection. To address these
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 900950-1G | 04061826648308 |